Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

por Coyle, C., Cafferty, F. H., Vale, C., Langley, R. E.
Publicado 2016

Radiation-induced apoptosis in microvascular endothelial cells.

por Langley, R. E., Bump, E. A., Quartuccio, S. G., Medeiros, D., Braunhut, S. J.
Publicado 1997

Comment on ‘Endocrine therapy in prostate cancer: time for re-appraisal of risks, benefits and cost-effectiveness?'

por Shah, S I A, Abel, P D, Langley, R E, Cafferty, F H
Publicado 2013

Co-enrolment of Participants into Multiple Cancer Trials: Benefits and Challenges

por Cafferty, F.H., Coyle, C., Rowley, S., Berkman, L., MacKensie, M., Langley, R.E.
Publicado 2017

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

por Langley, R E, Burdett, S, Tierney, J F, Cafferty, F, Parmar, M K B, Venning, G
Publicado 2011

Doppler assessment of the uterine circulation and the clinical behaviour of gestational trophoblastic tumours requiring chemotherapy.

por Long, M. G., Boultbee, J. E., Langley, R., Newlands, E. S., Begent, R. H., Bagshawe, K. D.
Publicado 1992

Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction

por Allum, W. H., Smyth, E. C., Blazeby, J. M., Grabsch, H. I., Griffin, S. M., Rowley, S., Cafferty, F. H., Langley, R. E., Cunningham, D.
Publicado 2019

Parenteral oestrogen in the treatment of prostate cancer: a systematic review

por Norman, G, Dean, M E, Langley, R E, Hodges, Z C, Ritchie, G, Parmar, M K B, Sydes, M R, Abel, P, Eastwood, A J
Publicado 2008

Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity through Toll-like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis

por Turner, Joseph D., Langley, R. Stuart, Johnston, Kelly L., Gentil, Katrin, Ford, Louise, Wu, Bo, Graham, Maia, Sharpley, Faye, Slatko, Barton, Pearlman, Eric, Taylor, Mark J.
Publicado 2009

Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis surve...

por van de Kerkhof, P.C.M., Reich, K., Kavanaugh, A., Bachelez, H., Barker, J., Girolomoni, G., Langley, R.G., Paul, C.F., Puig, L., Lebwohl, M.G.
Publicado 2015

Long‐term safety of certolizumab pegol in plaque psoriasis: pooled analysis over 3 years from three phase III, randomized, placebo‐controlled studies

por Blauvelt, A., Paul, C., van de Kerkhof, P., Warren, R.B., Gottlieb, A.B., Langley, R.G., Brock, F., Arendt, C., Boehnlein, M., Lebwohl, M., Reich, K.
Publicado 2020

Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis

por Gordon, K.B., Lebwohl, M., Papp, K.A., Bachelez, H., Wu, J.J., Langley, R.G., Blauvelt, A., Kaplan, B., Shah, M., Zhao, Y., Sinvhal, R., Reich, K.
Publicado 2021

Macrofilaricidal Activity after Doxycycline Only Treatment of Onchocerca volvulus in an Area of Loa loa Co-Endemicity: A Randomized Controlled Trial

por Turner, Joseph D., Tendongfor, Nicholas, Esum, Mathias, Johnston, Kelly L., Langley, R. Stuart, Ford, Louise, Faragher, Brian, Specht, Sabine, Mand, Sabine, Hoerauf, Achim, Enyong, Peter, Wanji, Samuel, Taylor, Mark J.
Publicado 2010

Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

por Hewitt, L.C., Inam, I.Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G.E., Melotte, V., Langley, R.E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G.G., Grabsch, H.I.
Publicado 2018

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl...

por Blauvelt, A., Papp, K., Gottlieb, A., Jarell, A., Reich, K., Maari, C., Gordon, K.B., Ferris, L.K., Langley, R.G., Tada, Y., Lima, R.G., Elmaraghy, H., Gallo, G., Renda, L., Park, S.Y., Burge, R., Bagel, J.
Publicado 2020

Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study

por Frouws, M A, Bastiaannet, E, Langley, R E, Chia, W K, van Herk-Sukel, M P P, Lemmens, V E P P, Putter, H, Hartgrink, H H, Bonsing, B A, Van de Velde, C J H, Portielje, J E A, Liefers, G J
Publicado 2017

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded t...

por Blauvelt, A., Leonardi, C., Elewski, B., Crowley, J.J., Guenther, L.C., Gooderham, M., Langley, R.G., Vender, R., Pinter, A., Griffiths, C.E.M., Tada, Y., Elmaraghy, H., Lima, R.G., Gallo, G., Renda, L., Burge, R., Park, S.Y., Zhu, B., Papp, K.
Publicado 2020

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial

por Smyth, E C, Nyamundanda, G, Cunningham, D, Fontana, E, Ragulan, C, Tan, I B, Lin, S J, Wotherspoon, A, Nankivell, M, Fassan, M, Lampis, A, Hahne, J C, Davies, A R, Lagergren, J, Gossage, J A, Maisey, N, Green, M, Zylstra, J L, Allum, W H, Langley, R E, Tan, P, Valeri, N, Sadanandam, A
Publicado 2018

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

por Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R J, Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D
Publicado 2019

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: A...

por Clarke, N.W., Ali, A., Ingleby, F.C., Hoyle, A., Amos, C.L., Attard, G., Brawley, C.D., Calvert, J., Chowdhury, S., Cook, A., Cross, W., Dearnaley, D.P., Douis, H., Gilbert, D., Gillessen, S., Jones, R.J., Langley, R.E., MacNair, A., Malik, Z., Mason, M.D., Matheson, D., Millman, R., Parker, C.C., Ritchie, A.W.S., Rush, H., Russell, J.M., Brown, J., Beesley, S., Birtle, A., Capaldi, L., Gale, J., Gibbs, S., Lydon, A., Nikapota, A., Omlin, A., O’Sullivan, J.M., Parikh, O., Protheroe, A., Rudman, S., Srihari, N.N., Simms, M., Tanguay, J.S., Tolan, S., Wagstaff, J., Wallace, J., Wylie, J., Zarkar, A., Sydes, M.R., Parmar, M.K.B., James, N.D.
Publicado 2020